DrugsNews.net

Drugs Xagena

Xagena Mappa
Medical Meeting
Onco News
XagenaNewsletter

Search results for "Skyrizi"

The European Commission ( EC ) has approved Skyrizi ( Risankizumab ) for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy. Skyrizi ( 150 m ...